De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

HMC Capital Toekomstige groei

Future criteriumcontroles 4/6

HMC Capital zal naar verwachting groeien in winst en omzet met respectievelijk 19.1% en 22.1% per jaar. De winst per aandeel zal naar verwachting groeien met 17.4% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.3% zijn.

Belangrijke informatie

19.1%

Groei van de winst

17.4%

Groei van de winst per aandeel

Capital Markets winstgroei	11.1%
Inkomstengroei	22.1%
Toekomstig rendement op eigen vermogen	9.3%
Dekking van analisten	Good
Laatst bijgewerkt	02 Oct 2024

Recente toekomstige groei-updates

Recent updates

What You Need To Know About The Home Consortium Limited (ASX:HMC) Analyst Downgrade Today

Dec 28

Home Consortium Limited (ASX:HMC) On The Verge Of Breaking Even

May 05

Analysts Expect Home Consortium Limited (ASX:HMC) To Breakeven Soon

Dec 31

Could The Home Consortium Limited (ASX:HMC) Ownership Structure Tell Us Something Useful?

Nov 26

Winst- en omzetgroeiprognoses

ASX:HMC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (AUD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
6/30/2027	244	157	142	148	5
6/30/2026	219	136	127	134	5
6/30/2025	195	114	113	119	5
6/30/2024	94	66	26	26	N/A
3/31/2024	88	61	21	21	N/A
12/31/2023	82	55	16	16	N/A
9/30/2023	85	56	8	8	N/A
6/30/2023	87	57	0	0	N/A
3/31/2023	110	53	-3	-3	N/A
12/31/2022	132	49	-6	-6	N/A
9/30/2022	149	63	-2	-2	N/A
6/30/2022	167	77	2	2	N/A
3/31/2022	146	35	6	6	N/A
12/31/2021	125	-7	11	11	N/A
9/30/2021	102	-53	17	17	N/A
6/30/2021	79	-100	23	23	N/A
3/31/2021	72	-68	18	18	N/A
12/31/2020	66	-36	13	13	N/A
9/30/2020	64	-15	-5	-5	N/A
6/30/2020	62	6	-23	-23	N/A
3/31/2020	60	-8	-40	-40	N/A
12/31/2019	57	-21	-57	-57	N/A
9/30/2019	53	-22	-54	-54	N/A
6/30/2019	49	-23	-50	-50	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei HMC ( 19.1% per jaar) ligt boven de spaarquote ( 2.4% ).

Winst versus markt: De winst van HMC ( 19.1% per jaar) zal naar verwachting sneller groeien dan de Australian markt ( 12.2% per jaar).

Hoge groeiwinsten: De winst van HMC zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van HMC ( 22.1% per jaar) zal naar verwachting sneller groeien dan de markt Australian ( 5.6% per jaar).

Hoge groei-inkomsten: De omzet van HMC ( 22.1% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen HMC zal naar verwachting over 3 jaar laag zijn ( 9.3 %).

HMC Capital Toekomstige groei

Future criteriumcontroles 4/6

Belangrijke informatie

Recente toekomstige groei-updates

Price target increased by 8.0% to AU$6.13

Consensus EPS estimates increase by 26%

Price target increased by 7.7% to AU$5.26

Consensus EPS estimates fall by 19%

Price target increased to AU$6.90

Price target increased to AU$5.85

Recent updates

HMC Capital Limited (ASX:HMC) acquired Market Central Lutwyche from Abacus Group (ASX:ABG) and ISPT Retail Australia Property Trust managed by ISPT Pty Ltd for approximately AUD 120 million.

Final dividend of AU$0.06 announced

HMC Capital Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2024, Payable on October 2, 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

HMC Capital Limited to Report Fiscal Year 2024 Results on Aug 21, 2024

HMC Capital Limited (ASX:HMC) completed the acquisition of Payton Capital Ltd

New minor risk - Shareholder dilution

HMC Capital Limited has completed a Follow-on Equity Offering in the amount of AUD 100.000004 million.

HMC Capital Limited has filed a Follow-on Equity Offering in the amount of AUD 30.000003 million.

Now 20% undervalued

First half 2024 earnings released: FFO per share: AU$0.2 (vs AU$0.084 in 1H 2023)

Price target increased by 8.0% to AU$6.13

Consensus EPS estimates increase by 26%

Now 21% overvalued after recent price rise

HMC Capital Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 18%

Insufficient new directors

Now 20% undervalued after recent price drop

HMC Capital Limited (ASX:HMC) and HealthCo Healthcare and Wellness REIT (ASX:HCW) completed the acquisition of Healthscope Portfolio from Medical Properties Trust, Inc. (NYSE:MPW).

HMC Capital Limited, Annual General Meeting, Nov 15, 2023

Now 20% undervalued

Price target increased by 7.7% to AU$5.26

HMC Capital Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on October 4, 2023

Full year 2023 earnings released: EPS: AU$0.18 (vs AU$0.26 in FY 2022)

HMC Capital Limited to Report Fiscal Year 2023 Results on Aug 23, 2023

Independent Non-Executive Director recently bought AU$250k worth of stock

Consensus EPS estimates fall by 19%

First half 2023 earnings released: FFO per share: AU$0.08 (vs AU$0.10 in 1H 2022)

Now 21% undervalued

HMC Capital Limited to Report First Half, 2023 Results on Feb 23, 2023

Home Consortium Limited Announces Board Changes

Insufficient new directors

Home Consortium Limited, Annual General Meeting, Nov 23, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Home Consortium Limited Announces Ordinary Dividend for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Home Consortium Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Home Consortium Limited's wholly owned subsidiary HMC Investment Management Limited Launches HMC Capital Partners Fund 1

High number of new and inexperienced directors

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Home Consortium Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 7, 2022

Home Consortium Limited (ASX:HMC) agreed to acquire Aventus Group (ASX:AVN).

Home Consortium Limited to Report First Half, 2022 Results on Feb 24, 2022

Now 20% undervalued after recent price drop

MD, CEO & Director recently bought AU$501k worth of stock

What You Need To Know About The Home Consortium Limited (ASX:HMC) Analyst Downgrade Today

Key Executive recently bought AU$151k worth of stock

Price target increased to AU$6.90

Independent Non-Executive Director recently bought AU$125k worth of stock

Price target increased to AU$5.85

Full year 2021 earnings released

Price target increased to AU$4.97

Home Consortium Limited (ASX:HMC) acquired portfolio of 8 private oncology assets from Genesis Care Pty Ltd for approximately AUD 110 million.

Forecast breakeven pushed back to 2022

Home Consortium Limited (ASX:HMC) entered into an agreement to acquire Five Dock (Childcare), NSW for AUD 13.1 million.

Home Consortium Limited Reaffirms FFO Guidance for the Fiscal Year 2021

Home Consortium Limited (ASX:HMC) On The Verge Of Breaking Even

Revenue beats expectations, earnings disappoint

First half 2021 earnings released: FFO AU$0.082 per share (vs AU$0.075 loss in 1H 2020)

New 90-day low: AU$3.73

Home Consortium Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$4.24

Analysts Expect Home Consortium Limited (ASX:HMC) To Breakeven Soon

Home Consortium Limited (ASX:HMC) agreed to acquire Portfolio of 6 health, education and Government services properties for approximately AUD 130 million.

Could The Home Consortium Limited (ASX:HMC) Ownership Structure Tell Us Something Useful?

Home Consortium Limited Elects Kelly Odwyer as Director

New 90-day high: AU$3.98

New 90-day high: AU$3.85

Christopher Saxon to Assume the Role of Independent Chairman of Home Consortium Limited from 1 January 2021

New 90-day high: AU$3.45